HR
Healthcare Realty Trust Incorporated
$17.98
+0.03
(+0.17%)
Mkt Cap
6.24B
Volume
5,360,338
52W Range
16.31-22.04
Sector
Real Estate
Beta
0.84
EPS (TTM)
-0.26 USD
P/E Ratio
-23.87
Revenue (TTM)
1.14B USD
Rev Growth (5Y)
+9.9%
EPS Growth (5Y)
N/A
AlphaVal · Fair Value
What we estimate one share is worth
$19.24
Fair Value
weak signal
6.6% below fair value
Modeled from cash flows & growth.
AlphaQuality · Grade · Gated
How strong & durable the business is
F
Real Estate Investment Trust
30.0 / 100 pillar composite (overridden)
A real-estate investment trust — graded A–F vs. similar companies.
Company Description
Healthcare Realty Trust operates as a Real Estate Investment Trust (REIT), specializing in the acquisition, development, financing, and active management of income-generating real estate assets, predominantly serving outpatient healthcare providers throughout the United States. By September 30, 2020, its extensive portfolio comprised 211 properties located across 24 states, collectively spanning 15.5 million square feet and valued at approximately $5.5 billion. The company further provided comprehensive leasing and property management solutions for 11.9 million square feet nationwide.
Track Record
Showing latest 4 periods • Swipe for more
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.18B | 1.27B | 1.34B | 932.64M | 534.82M | 735.07M | 693.63M | 695.30M | 613.11M | 460.48M | 403.41M | 371.05M |
| Net Income | (246.07M) | (654.49M) | (278.26M) | 40.90M | 66.66M | 52.62M | 30.15M | 213.46M | 63.92M | 49.95M | 32.93M | 45.37M |
| EPS | -0.71 | -1.81 | -0.74 | 0.15 | 0.45 | 0.24 | 0.15 | 1.04 | 0.35 | 0.34 | 0.26 | 0.38 |
| Free Cash Flow | 126.94M | 252.64M | 268.79M | 109.20M | 131.94M | 376.13M | 148.47M | 137.55M | 99.15M | 79.84M | 111.61M | 54.70M |
| FCF / Share | 0.36 | 0.69 | 0.71 | 0.43 | 0.93 | 1.72 | 0.72 | 0.67 | 0.55 | 0.58 | 0.89 | 0.46 |
| Operating CF | 457.10M | 501.62M | 499.82M | 272.75M | 232.63M | 470.09M | 213.14M | 208.35M | 179.77M | 151.27M | 160.38M | 125.37M |
| Total Assets | 9.21B | 10.65B | 12.64B | 13.85B | 4.26B | 3.81B | 3.56B | 3.19B | 3.19B | 3.04B | 2.82B | 2.76B |
| Total Debt | 4.15B | 4.96B | 5.30B | 5.70B | 1.92B | 1.71B | 1.52B | 1.35B | 1.28B | 1.26B | 1.43B | 1.40B |
| Cash & Equiv | 26.17M | 68.92M | 25.70M | 60.96M | 13.18M | 15.30M | 657,000 | 8.38M | 6.21M | 5.41M | 4.10M | 3.52M |
| Book Value | 4.62B | 5.23B | 6.82B | 7.57B | 2.19B | 1.95B | 1.90B | 1.72B | 1.79B | 1.65B | 1.24B | 1.22B |
| Return on Equity | -0.05 | -0.13 | -0.04 | 0.01 | 0.03 | 0.03 | 0.02 | 0.12 | 0.04 | 0.03 | 0.03 | 0.04 |
| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 281.85M | 278.99M | 286.30M | 297.76M | 297.50M | 298.98M | 309.77M | 315.42M | 316.32M | 326.81M | 330.44M | 342.26M |
| Net Income | (43.51M) | (56,000) | 14.39M | (57.74M) | (157.85M) | (44.87M) | (106.85M) | (93.02M) | (143.78M) | (310.84M) | (40.53M) | (67.84M) |
| EPS | -0.13 | -0.00 | 0.04 | -0.17 | -0.45 | -0.13 | -0.31 | -0.26 | -0.39 | -0.82 | -0.11 | -0.18 |
| Free Cash Flow | 72.39M | (8.28M) | 45.79M | 24.93M | 77.56M | (21.34M) | 75.77M | 50.33M | 100.77M | 25.76M | 53.16M | 55.32M |
| FCF / Share | 0.21 | -0.02 | 0.13 | 0.07 | 0.22 | -0.06 | 0.22 | 0.14 | 0.27 | 0.07 | 0.14 | 0.15 |
| Operating CF | 142.19M | 52.88M | 132.34M | 113.75M | 163.22M | 47.79M | 138.01M | 119.30M | 168.15M | 76.15M | 127.32M | 118.18M |
| Total Assets | 9.00B | 9.15B | 9.21B | 9.86B | 10.24B | 10.50B | 10.65B | 11.24B | 11.80B | 12.28B | 12.64B | 13.10B |
| Total Debt | 4.40B | 4.34B | 4.15B | 4.72B | 4.97B | 5.03B | 4.96B | 5.26B | 5.45B | 5.41B | 5.30B | 5.57B |
| Cash & Equiv | 18.99M | 26.23M | 26.17M | 43.34M | 25.51M | 25.72M | 68.92M | 22.80M | 41.77M | 26.17M | 25.70M | 24.67M |
| Book Value | 4.22B | 4.44B | 4.62B | 4.68B | 4.82B | 5.08B | 5.23B | 5.52B | 5.89B | 6.42B | 6.82B | 7.00B |
| Return on Equity | -0.01 | -0.00 | 0.00 | -0.01 | -0.03 | -0.01 | -0.02 | -0.02 | -0.02 | -0.05 | -0.01 | -0.01 |
HR News
Ivonescimab Plus Chemotherapy Demonstrates Overall Survival Superiority Compared to Durvalumab Plus Chemotherapy in First-Line Treatment of Patients with Advanced Biliary Tract Cancer in HARMONi-GI1 S
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Akamai Technolgies, Apple, Blackrock, Ford Motor, Healthcare Realty Trust, Noble, Sunoco LP, Venture Global, Western Midstream Partners, Zoetis, and More
Lilly to showcase advances across its oncology pipeline at the 2026 European Society for Medical Oncology (ESMO) Congress
Healthcare Realty Trust Releases Eighth Corporate Responsibility Report
Healthcare Realty Trust Announces Third Quarter Earnings Release Date and Conference Call
Pensionfund PDN Acquires 59,719 Shares of Healthcare Realty Trust Incorporated $HR
Corient Private Wealth LP Purchases 30,584 Shares of Healthcare Realty Trust Incorporated $HR
State Street Corp Reduces Stock Position in Healthcare Realty Trust Incorporated $HR
Down 5.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Healthcare Realty Trust (HR)